Login to Your Account

Ark Therapeutics Raises £55M, Ends IPO Drought in London

By Nuala Moran

Wednesday, March 10, 2004
LONDON - Ark Therapeutics Group plc successfully completed its initial public offering last week, raising £55 million (US$102 million) as it joined the main market of the London Stock Exchange, the first biotechnology company to do so in more than three years. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription